The Analyst Verdict: Hologic In The Eyes Of 8 Experts
Portfolio Pulse from Benzinga Insights
Eight analysts have recently published ratings on Hologic (NASDAQ:HOLX), with a mix of bullish, somewhat bullish, and indifferent sentiments. The average 12-month price target has increased to $88.25. Key analysts have raised, maintained, or lowered their ratings and price targets based on recent developments.
July 30, 2024 | 1:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Eight analysts have provided mixed ratings for Hologic (NASDAQ:HOLX) over the past three months, with a slight increase in the average 12-month price target to $88.25. Key analysts have adjusted their ratings and price targets based on recent market conditions and company performance.
The mixed ratings from analysts, along with a slight increase in the average price target, suggest a cautiously optimistic outlook for Hologic. The adjustments in ratings and price targets by key analysts indicate a response to recent market conditions and company performance, which could positively impact the stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100